Insider Buying Amid a Broader Sell‑Off
On June 2 2026, Lilly III John Osborne executed the purchase of 12,415 restricted stock units (RSUs) of FIGMA INC‑CL A Class A common stock through a revocable living trust. The RSUs were valued at zero per share at the time of filing and will vest in accordance with the trust’s award schedule, thereby conferring a future claim on the company’s shares. Although the transaction adds only a modest quantity to Osborne’s holdings—raising the trust‑held balance to 62,922 shares—its timing is noteworthy against the backdrop of a company‑wide sell‑off that began on June 1 with senior executives liquidating millions of shares.
What the Move Signals for Investors
Osborne’s purchase occurred just hours after the market reacted negatively to CEO Dylan Field’s sale of 174,430 Class A shares, a move that triggered a 5 % drop in the stock price and drew bearish analyst coverage. The fact that another insider is adding to his position suggests that, at least at the individual level, some confidence remains in the firm’s long‑term prospects. Because the RSU structure does not provide immediate cash to Osborne—his benefit is tied to future performance—it can be interpreted as a long‑term view.
Investors observing the 52‑week low of $16.60 and the current price of $22.79 may see this as a counterpoint to the prevailing pessimism. However, the limited size of the purchase and the broader context of widespread selling temper any enthusiasm. The trade serves more as a subtle signal of confidence rather than an outright endorsement of a rebound.
How the Transaction Fits Osborne’s Historical Pattern
Osborne’s transaction history is sparse. His only prior filing in the last 18 months was a purchase of 422 shares on November 13 2025, which brought his trust balance to 62,922 shares at that time. The new RSU purchase merely maintains that level, suggesting a consistent, incremental approach rather than a speculative “buy‑the‑dip” play. Historically, insiders of FIGMA have tended to sell large blocks—often as part of Rule 10b‑5‑1 plans—rather than accumulate shares. Osborne’s pattern of holding a relatively small, steady position, coupled with the choice of RSUs, indicates a preference for long‑term alignment with shareholders rather than short‑term trading.
Implications for FIGMA’s Future Outlook
The company’s fundamentals remain shaky: a negative P/E of –6.88, a 52‑week high of $142.92, and a 1‑year decline of 80.51 % underscore the pressure on the stock. Yet insider buying—especially when structured as RSUs—can signal management confidence that may influence market sentiment over time. Analysts are likely to weigh the modest insider purchase against the larger context of executive sell‑offs and a bearish market environment.
For investors, the key takeaway is that while the current trade is small and does not offset the significant capital outflows, it does not confirm a widespread shift in insider optimism. Those monitoring FIGMA’s trajectory should continue to watch for further insider activity, earnings updates, and any corporate initiatives that could alter the company’s valuation narrative.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026‑06‑02 | Lilly III John Osborne () | Buy | 12,415.00 | N/A | Class A Common Stock |
| N/A | Lilly III John Osborne () | Holding | 62,922.00 | N/A | Class A Common Stock |
| 2026‑06‑02 | Radakovich Lynn Vojvodich () | Buy | 12,415.00 | N/A | Class A Common Stock |
| 2026‑06‑02 | Kramer Kelly A. () | Buy | 12,415.00 | N/A | Class A Common Stock |




